

Lead Product(s) : Streptococcus Thermophilus
Therapeutic Area : Gastroenterology
Study Phase : Undisclosed
Sponsor : Ferryx Limited
Deal Size : Inapplicable
Deal Type : Inapplicable
Details : Streptococcus Thermophilus is a probiotic candidate, which is currently being evaluated in clinical studies for the treatment of Gut Inflammation.
Product Name : Undisclosed
Product Type : Probiotic
Upfront Cash : Inapplicable
November 28, 2025
Lead Product(s) : Streptococcus Thermophilus
Therapeutic Area : Gastroenterology
Highest Development Status : Undisclosed
Sponsor : Ferryx Limited
Deal Size : Inapplicable
Deal Type : Inapplicable
